| Dr Arsalan Augend, DDS | |
|
5201 Washington Ave, Suite A, Mount Pleasant, WI 53406-4242 | |
| (720) 210-3078 | |
| Not Available |
| Full Name | Dr Arsalan Augend |
|---|---|
| Gender | Male |
| Speciality | Dentist |
| Location | 5201 Washington Ave, Mount Pleasant, Wisconsin |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1053778803 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 122300000X | Dentist | 1001259 - 15 (Wisconsin) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Arsalan Augend, DDS 2050 E Algonquin Rd, Suite 610, Schaumburg, IL 60173-4144 Ph: (720) 210-3078 | Dr Arsalan Augend, DDS 5201 Washington Ave, Suite A, Mount Pleasant, WI 53406-4242 Ph: (720) 210-3078 |
News Archive
Tenet Healthcare Corporation today confirmed that it has received a revised proposal from Community Health Systems, Inc. to acquire all of the outstanding shares of Tenet for $6.00 per share in cash.
The p53 tumor suppressor, a transcription factor that activates or inhibits hundreds of genes, either directly or indirectly, triggers a variety of cellular effects and plays a central role in the cellular defense against cancer. One of the main approaches for pharmacological intervention is to activate wild-type p53 in cancer cells by blocking MDM2 from binding to p53.
The U.S. Food and Drug Administration today approved Truxima (rituximab-abbs) as the first biosimilar to Rituxan (rituximab) for the treatment of adult patients with CD20-positive, B-cell non-Hodgkin's lymphoma (NHL) to be used as a single agent or in combination with chemotherapy.
Not only does our way of life determine how long we live but so too does our genetic material. Of particular importance here is a genetic program that is controlled by the insulin receptor. A team of researchers from the Universities of Cologne and Bonn has now discovered how protein aggregation affects this genetic program and thus triggers aging.
Biogen Idec and Swedish Orphan Biovitrum today announced that they have restructured the collaboration agreement for the companies' long-acting, recombinant Factor VIII Fc fusion protein (rFVIIIFc) in hemophilia A patients and the recombinant Factor IX Fc fusion protein (rFIXFc) in hemophilia B patients.
› Verified 6 days ago
Dr. Aubrey Lukas, DDS Dentist Medicare: Medicare Enrolled Practice Location: 3528 Meachem Rd, Mount Pleasant, WI 53405 Phone: 262-598-8750 | |
Dr. Thomas James Gorski, DDS Dentist Medicare: Medicare Enrolled Practice Location: 1101 S Airline Rd, Mount Pleasant, WI 53406 Phone: 414-758-4714 | |
Dr. Osman Mir Khan, DMD Dentist Medicare: Not Enrolled in Medicare Practice Location: 6100 Washington Ave Ste F2, Mount Pleasant, WI 53406 Phone: 262-999-9998 | |
Sanaa Bhimji, DMD Dentist Medicare: Medicare Enrolled Practice Location: 5201 Washington Ave, Ste A, Mount Pleasant, WI 53406 Phone: 888-988-4066 Fax: 847-496-4850 | |
Dr. Lisa Lyn Sanfelippo, DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: 5201 Washington Ave, Mount Pleasant, WI 53406 Phone: 888-988-4066 Fax: 847-496-4850 | |
Dorina Nastase, DMD Dentist Medicare: Medicare Enrolled Practice Location: 5201 Washington Ave, Suite A, Mount Pleasant, WI 53406 Phone: 888-988-4066 Fax: 847-496-4850 |